Further investigation into the functional properties of these expanded T cell clones and their interactions with other immune cells would be essential to fully understand their contribution to treatment outcomes and guide the development of personalized immunotherapeutic strategies for cancer patients undergoing anti- PD1 therapy. This evidence concerns the gene PDCD1 and cancer.